Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,855.8
-1.7 (-0.06%)

 

  • STI Straits Times Index
    2,855.8
    -1.7 (-0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,607.6
    -4.5 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,894.7
    75.2 (0.28%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,408.3
    38.6 (1.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    26,644.7
    107.4 (0.40%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,783.3
    23.4 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,405.7M
  • Value: 1,046.1M
  • Rise: 173
  • Fall: 135
  • Unch: 466

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Alset0.083+0.019
Oceanus^0.025-0.002
Jiutian Chemical0.088+0.001
Sembcorp Marine0.168-0.001
Intl Cement0.071+0.002
QT Vascular0.007-
Broadway Ind0.163+0.006
YZJ Shipbldg SGD0.920-0.010
ThaiBev0.750+0.005
Adventus0.027-

World Indices

World Indices
Name Last Change
Nasdaq 12,094.4 +57.6
HSI 26,894.7 +75.2
HSCEI 10,790.3 +88.8
Jakarta 5,783.3 +23.4
Nikkei 225 26,644.7 +107.4
SSE Comp 3,408.3 +38.6
Shanghai A 3,572.4 +40.5
Shanghai B 244.7 -1.3
KOSPI 2,633.4 +7.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MESOBLAST LTD SPON ADR EACH REP 5 SHS MESOBLAST LIMITED SPONSORED ADR
Updated on 27 Nov 2020 (End of trading day)
Last (USD): 14.930 Change: -0.350 High: 15.380 Remarks: -
Change (%): -2.29 Low: 14.810
Open 15.310 Yesterday's Close 15.28
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 240,777 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.66278 Trailing EPS (USD) e -0.83374 NAV (USD) b 4.5824
PE a - Trailing PE f - Price / NAV b 3.2581
Dividend (USD) d - Cash In Hand (USD) g 0.9201 Issued & Paid-up Shares c 117,517,000
Dividend Yield (%) d - Price / Cash In Hand g 16.226 Treasury Shares h 700,000
Market Cap (M) 1,754.529 Enterprise Value (M) 1,747.429
Piotroski F Score 4 Exchange Code MESO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 135.25 Free Float (%) 85.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 27 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Mar 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MESOBLAST LTD SPON ADR EACH REP 5 SHS NASDAQ 1,754.529 - - 3.2581 -
Industry Biotechnology NASDAQ 2,815.140 458.260 - 6.5922 0.612
Local Peer AMGEN INC NASDAQ 130,877.413 16.689 17.802 11.9425 2.621
Local Peer GILEAD SCIENCES INC NASDAQ 75,249.406 13.971 59.345 4.3135 4.240
Local Peer VERTEX PHARMACEUTICAL NASDAQ 58,953.215 50.096 21.910 7.2482 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,852.204 25.925 17.380 5.4172 -
Local Peer MODERNA INC NASDAQ 50,267.041 - - 18.2140 -
Local Peer ILLUMINA INC NASDAQ 46,286.380 46.194 72.549 9.8482 -
Local Peer BIOGEN INC NASDAQ 37,513.354 6.371 7.381 3.4869 -
Local Peer SEAGEN INC NASDAQ 30,493.351 - 64.549 13.5044 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,099.576 11.271 28.329 2.4469 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 26,196.648 - - 24.0810 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 25,910.782 - - 6.0433 -
Local Peer 10X GENOMICS INC NASDAQ 23,812.595 - - 28.8612 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), NOVAVAX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), IMMUNOVANT INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), VIELA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PRECIGEN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), PERSONALIS INC (NASDAQ), COMPUGEN (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ALECTOR INC (NASDAQ), NANTKWEST INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ARVINAS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), AKOUOS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), IMMATICS N V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IVERIC BIO INC (NASDAQ), AVROBIO INC (NASDAQ), GERON CORP (NASDAQ), ATRECA INC (NASDAQ), ARDELYX INC (NASDAQ), ONCORUS INC (NASDAQ), XBIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HUMANIGEN INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), AFFIMED N V (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CABALETTA BIO INC (NASDAQ), XOMA CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), MEDICINOVA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), IMV INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHIMERIX INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), METACRINE INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), BIOVIE INC (NASDAQ), EQUILLIUM INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), INMUNE BIO INC (NASDAQ), ORGENESIS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), IMMUNOME INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SAVARA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), HISTOGEN INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ)
Global Peer CSL ASX 137,857.122 43.955 43.955 14.5410 0.969
Global Peer WUXI BIO HKEx 310,653.898 - - - -
Global Peer BEIGENE HKEx 187,206.682 - - 5.6340 -
Global Peer SINO BIOPHARM HKEx 143,158.785 46.642 52.054 4.1462 0.701
Global Peer ZAI LAB-SB HKEx 70,040.774 - - 19.4149 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,389.915 80.549 26.350 3.5077 -
Global Peer GENSCRIPT BIO HKEx 21,062.251 - - 2.8807 -
Global Peer 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Global Peer MYOVANT SCIENCES LTD NYSE 2,131.667 - - -10.6702 -
Other Global Peers ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), JW THERAP-B (HKEx), JHBP-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), ASCENTAGE-B (HKEx), DPHARMA (Bursa), TELIX PHARMACEUTIC (ASX), OPTHEA LIMITED (ASX), KINTOR PHARMA-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), NEXT SCIENCE LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), MEMPHASYS LTD (ASX), BIONOMICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), CT ENTERPRISE (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), GENETIC TECHNOLOGIES (ASX), REGENT PACIFIC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), Suntar Eco-City (SGX), BIOSINO BIO-TEC (HKEx), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), ORAGENICS INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.130
+26.53 %
10 Days -+3.120
+26.42 %
20 Days -+4.510
+43.28 %
Medium Term Return 3 Months --3.400
-18.55 %
6 Months -+1.730
+13.11 %
1 Year -+8.580
+135.12 %
Long Term Return 2 Years -+10.100
+209.11 %
3 Years -+9.970
+201.01 %
5 Years -+9.180
+159.65 %
Annualised Return Annualised --
+21.03 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.120 - 21.280 Change From 1 Year Low +11.810 % Change From 1 Year Low (%) +378.51
Change From 1 Year High -6.350 % Change From 1 Year High (%) -29.84
2 Years Range 3.120 - 21.280 Change From 2 Years Low +11.810 % Change From 2 Years Low (%) +378.51
Change From 2 Years High -6.350 % Change From 2 Years High (%) -29.84
5 Years Range 3.120 - 21.280 Change From 5 Years Low +11.810 % Change From 5 Years Low (%) +378.51
Change From 5 Years High -6.350 % Change From 5 Years High (%) -29.84
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
27 Nov 2020 15.310 15.380 14.810 14.930 240,777 -
25 Nov 2020 15.900 15.900 15.200 15.280 419,058 -
24 Nov 2020 16.200 17.411 16.200 16.740 751,722 -
23 Nov 2020 15.180 15.820 15.000 15.810 1,101,446 -
20 Nov 2020 13.880 14.869 13.250 13.780 2,014,391 -
19 Nov 2020 11.950 11.950 11.650 11.790 343,789 -
18 Nov 2020 11.930 12.070 11.740 11.800 268,546 -
17 Nov 2020 11.980 11.980 11.580 11.760 246,227 -
16 Nov 2020 12.000 12.050 11.580 11.990 363,978 -
13 Nov 2020 11.480 12.050 11.450 11.880 205,411 -
12 Nov 2020 11.720 11.770 11.280 11.450 153,429 -
11 Nov 2020 12.000 12.100 11.650 11.810 369,804 -
10 Nov 2020 11.020 11.630 10.950 11.610 321,087 -
09 Nov 2020 11.410 11.870 10.350 10.540 670,093 -
06 Nov 2020 11.780 11.910 11.650 11.730 181,413 -
05 Nov 2020 11.740 11.990 11.537 11.890 244,836 -
04 Nov 2020 11.300 11.650 11.300 11.420 168,773 -
03 Nov 2020 10.960 11.340 10.899 11.260 216,980 -
02 Nov 2020 10.680 10.910 10.510 10.850 234,937 -
30 Oct 2020 11.000 11.110 10.500 10.700 287,465 -
29 Oct 2020 10.860 11.050 10.610 10.900 305,732 -
28 Oct 2020 10.300 10.650 10.220 10.420 377,432 -
Summary
Current 2 Weeks
(13 Nov 2020 to 27 Nov 2020)
11.480 17.411 11.450 14.930 5,955,345 -
Previous 2 Weeks
(30 Oct 2020 to 12 Nov 2020)
11.000 17.411 10.500 11.450 2,848,817 -
4 Weeks from
(02 Oct 2020 to 29 Oct 2020)
11.910 17.411 11.090 10.900 15,449,638 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.